Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,838 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Follow-Up Questions
Hiệu suất giá của cổ phiếu TKBIF như thế nào?
Giá hiện tại của TKBIF là $0, đã decreased 0% trong ngày giao dịch cuối cùng.
Vốn hóa thị trường của Takara Bio Inc là bao nhiêu?
Vốn hóa thị trường hiện tại của Takara Bio Inc là $NaN
Có nên mua, bán hay nắm giữ Takara Bio Inc?
Theo các nhà phân tích phố Wall, 5 nhà phân tích đã đưa ra xếp hạng phân tích cho Takara Bio Inc, bao gồm 1 mua mạnh, 3 mua, 4 nắm giữ, 0 bán, và 1 bán mạnh
